Skip to main content

Kaposi's Sarcoma clinical trials at UCSF

2 research studies open to eligible people

Kaposi's sarcoma is a cancer that forms in the cells lining blood vessels. UCSF is collecting blood and tissue samples to research HIV-related cancers, including Kaposi's sarcoma. UCSF is also studying the drug ixazomib to see if it stops tumor growth in people with Kaposi's sarcoma.

Showing trials for
  • Ixazomib for Kaposi Sarcoma

    open to eligible people ages 18 years and up

    This phase II trial studies how well ixazomib works in treating patients with Kaposi sarcoma. Ixazomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

    San Francisco, California and other locations

  • Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

    open to eligible people ages 18 years and up

    This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors related to HIV and cancers that occur commonly in people living with HIV.

    San Francisco, California and other locations

Last updated: